FDA Inspection
Recipharm MontsRecipharm Monts – FDA Inspection, Mar 29, 2019
Record Details
This FDA Inspection record concerns Recipharm Monts, with an inspection on March 29, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA DavisM (Issuing Officer)
View Company Profile
ID · 6d6f7f96-cd3d-4333-9ca1-8e5e161ed82d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1116762
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Recipharm Monts
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 18, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 9, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Recipharm Monts
- FDA Inspection 1181620 - 2022-10-18
- FDA Inspection 940945 - 2015-06-09
- FDA Inspection 821445 - 2013-02-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.